Neuropathy affects millions of people worldwide, causing chronic pain, numbness, weakness, and loss of function in the ...

The Mayo Clinic Center for Regenerative Biotherapeutics manufactures a wide range of products for active, early-phase clinical trials.

Adipose tissue-derived mesenchymal Stem Cells (ADSCs) can be used to stimulate neovascularization and reduce the risk of TRAM flap necrosis. Aim Determine the effect of ADSCs on TRAM flap viability in ...

The first Korean company granted Breakthrough Therapy Designation (BTD) from the U.S. FDA-Clinical trials and results from a three-year follow-up show significant improvements compared to existing ...

Cx601 is a suspension of allogeneic expanded adipose-derived stem cells (eASC) locally administered for the treatment of complex perianal fistulas in patients with non-active/mildly active luminal ...

Allogeneic stem cell therapy allows "off the shelf" cells ... TiGenix has a second adipose-derived product, Cx611, is undergoing a phase 1/2 trial in severe sepsis, a deadly condition which ...

Our blood consists of many cell types that develop through different stages from a precursor type -- the blood stem cell. An international research team has now investigated the developmental pathways ...

On March 12, 2025, China's Center for Drug Evaluation (CDE) approved Tasly's Investigational New Drug (IND) application for NR-20201, an allogeneic adipose-derived mesenchymal stromal cell, sparking ...

Feb. 4, 2025 — Researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into oral cancer at the earliest stages of the ... Jan. 31, 2025 — Prolonged ...

The University of New Haven is at the forefront of creating STEM (science, technology, engineering, and math) designated programs that are designed to instill in our students the technical expertise ...

Traumatic Brain Injury companies include Supernus Pharmaceuticals, Inc., Hope Biosciences, The SanBio Group, Merz ...